A detailed history of Ever Source Wealth Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,322 shares of EXEL stock, worth $83,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,322
Previous 2,227 4.27%
Holding current value
$83,638
Previous $50,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$21.96 - $27.6 $2,086 - $2,622
95 Added 4.27%
2,322 $60,000
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $8,664 - $10,108
-426 Reduced 16.06%
2,227 $50,000
Q1 2024

Jun 11, 2024

SELL
$20.17 - $23.93 $1,754 - $2,081
-87 Reduced 3.18%
2,653 $62,000
Q4 2023

Feb 09, 2024

SELL
$19.25 - $24.13 $8,624 - $10,810
-448 Reduced 14.05%
2,740 $65,000
Q3 2023

Nov 03, 2023

SELL
$19.04 - $22.74 $10,719 - $12,802
-563 Reduced 15.01%
3,188 $69,000
Q2 2023

Aug 04, 2023

BUY
$18.17 - $20.48 $27,400 - $30,883
1,508 Added 67.23%
3,751 $71,000
Q1 2023

May 11, 2023

BUY
$16.3 - $19.41 $11,573 - $13,781
710 Added 46.31%
2,243 $43,000
Q4 2022

Feb 09, 2023

SELL
$14.96 - $17.39 $223,801 - $260,154
-14,960 Reduced 90.71%
1,533 $24,000
Q3 2022

Nov 07, 2022

BUY
$15.68 - $22.27 $258,610 - $367,299
16,493 New
16,493 $259,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.